UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NVS — Novartis AG
CIK 861177
NEW YORK, NY
Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,882,439
+$500,756 QoQ
Shares Held
126,866
-0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 1,603 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. NVS ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
|
36,157,306 | $870,667,923 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,882,439 | 126,866 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $19,381,683 | 126,885 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,054,647 | 22,156 | Shares | Defined | 2026-02-13 | |
| 2021-12-31 | $1,776,253 | 20,307 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,423,544 | 17,407 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,807,190 | 19,807 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,325,538 | 15,507 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,244,304 | 13,177 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $517,412 | 5,950 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $32,806,855 | 397,900 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||